Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 849 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Selventa signs research agreement with Janssen

The companies will develop disease models using diverse biologic data to elaborate disease-relevant mechanisms and find out potential new drug discovery opportunities. Selventa will leverage molecular patient data

Pfizer takes over Alacer

Alacer produces nearly 500m packets of Emergen-C annually, and its products are sold in health food stores, supermarkets, drug stores, mass merchandisers and club stores. Emergen-C is an

British Columbia to deal with drug shortages

Sandoz Canada has stopped production at its plant in Quebec after the US Food and Drug Administration raised safety and reliability issues at the facility. Health Shared Services

Nepal Drugs to restart operations

The public entity has remained closed since 2011 after it incurred massive losses, the The Himalayan Times reported. The company had reported a cumulative loss of NPR485.85m ($6.64m)